PODD (STOCKS)
Insulet Corporation
$148.140000
-1.560000 (-1.04%)
Prev close: $149.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Ashley A. McEvoy
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,264.34M
- Employees
- 3,900
- P/E (TTM)
- 34.84
- P/B (TTM)
- 7.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
12
Strong Buy
18
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$1.42 | $1.22 | +0.1979 | +16.19% |
|
Dec 2025 (Q4)
|
$1.55 | $1.48 | +0.0668 | +4.50% |
|
Sep 2025 (Q3)
|
$1.24 | $1.16 | +0.0757 | +6.50% |
|
Jun 2025 (Q2)
|
$1.17 | $0.95 | +0.2242 | +23.70% |
Financial Statements
| Revenues | $2.90B |
| Benefits Costs and Expenses | $2.50B |
| Cost Of Revenue | $841.00M |
| Costs And Expenses | $2.50B |
| Gross Profit | $2.06B |
| Operating Expenses | $1.55B |
| Selling, General, and Administrative Expenses | $1.22B |
| Research and Development | $331.20M |
| Operating Income/Loss | $507.20M |
| Income/Loss From Continuing Operations After Tax | $302.90M |
| Income/Loss From Continuing Operations Before Tax | $404.40M |
| Income Tax Expense/Benefit | $101.50M |
| Net Income/Loss | $302.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $302.80M |
| Net Income/Loss Available To Common Stockholders, Basic | $302.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $4.30 |
| Diluted Earnings Per Share | $4.29 |
| Basic Average Shares | 210,747,000 |
| Diluted Average Shares | 211,109,000 |
| Assets | $2.99B |
| Current Assets | $1.71B |
| Inventory | $462.50M |
| Other Current Assets | $1.25B |
| Noncurrent Assets | $1.28B |
| Liabilities | $1.68B |
| Current Liabilities | $687.50M |
| Accounts Payable | $149.80M |
| Other Current Liabilities | $537.70M |
| Noncurrent Liabilities | $997.10M |
| Equity | $1.30B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.30B |
| Liabilities And Equity | $2.99B |
| Net Cash Flow From Operating Activities | $619.30M |
| Net Cash Flow From Operating Activities, Continuing | $619.30M |
| Net Cash Flow From Investing Activities | -$234.80M |
| Net Cash Flow From Investing Activities, Continuing | -$234.80M |
| Net Cash Flow From Financing Activities | -$1.19B |
| Net Cash Flow From Financing Activities, Continuing | -$1.19B |
| Exchange Gains/Losses | $5.80M |
| Net Cash Flow | -$802.60M |
| Net Cash Flow, Continuing | -$808.40M |
| Comprehensive Income/Loss | $314.40M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $314.40M |
| Other Comprehensive Income/Loss | $314.40M |
| Other Comprehensive Income/Loss Attributable To Parent | $11.70M |